Pilot Study Comparison of Combigan Two Times Daily (BID) vs Simbrinza Three Times Daily (TID) in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2018
Price : $35 *
At a glance
- Drugs Brimonidine/timolol (Primary) ; Brimonidine/brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- 23 Oct 2018 Status changed from active, no longer recruiting to completed.
- 14 Mar 2018 Planned End Date changed from 1 Sep 2017 to 1 Apr 2018.
- 14 Mar 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.